"Not yet documented circulating antibodies indicates a carrier state that is associated with the ability to transmit infection. Uninfected persons are antibody-negative and are at risk of primary infection by blood component transfusion. Antibody-positive persons are susceptible to reinfection with a different viral strain or to reactivation of the latent virus they harbor. In most cases, CMV infection is clinically unimportant, but in some severely immunosuppressed individuals transfusion-transmitted CMV has life-threatening potential.
Groups said to be at risk of serious consequences from CMV are listed in Table 2 . In most medical centers, blood components that contain cellular elements are selected or processed in a way that will reduce or eliminate the risk of CMV transmission before transfusion into them.
The most common way to provide "CMV-negative" components for patients who are at risk is by testing the donor unit for antibodies to CMV and issuing only those components that test negative [4] . Because of the high prevalence of seropositivity in adult populations, this approach has proven difficult for many blood banks. There is a report that donors who have only IgM antibodies are the ones most likely to infect 7. Children with documented congenital immune deficiencies 8 . Heart, lung, or heart/lung transplant recipients recipients, but this datum is unconfirmed (5] . Washed or frozen-deglycerolized components seem to be an acceptable alternative, especially for newborns [6] . Recent reports that third-generation leukocyte filters are also effective are promising, especially so because of the ever-increasing demand for "CMV-negative" transfusions [7, 8] .
SYPHILIS
Transfusion-transmitted syphilis is almost non-existent today, despite the increase in reported primary and secondary syphilis. All donations are tested, using a serologic test for syphilis (STS), hence only those very few donors who are STS-negative but spirochetemic pose any risk. In addition, the spirochete does not survive well at 40C, the temperature at which red blood cell components are stored. For this reason, only red cell components stored for less than four days or platelets, which are stored at 220C, can transmit the disease. Occasional cases of transmission from platelets donated by such individuals have been reported [9] .
MALARIA
Although no cases of transfusion-related malaria have been reported to the Centers for Disease Control for the most recent two years, the risk of transmission remains. Worldwide travel and recent immigration patterns from endemic areas make it almost certain that cases will continue to occur. Because transfusion-transmited malaria is so infrequent, the correct diagnosis is often delayed. This fact is unfortunate because early treatment is effective, and delay can be fatal. Serologic testing can detect some carriers but is not indicated for donor screening. Current regulations do not allow individuals to donate for three years after they have had malaria, have taken malarial prophylaxis, or have visited in or immigrated from endemic areas. This screening approach is generally effective, as evidenced by the very low incidence of cases.
CHAGAS DISEASE
Chagas disease is widespread and well-known in the Western hemisphere, especially in South America, Central America, and Mexico. Perhaps as many as 10-15 million persons are infected, many of whom are essentially asymptomatic. Acute infection can be fatal, but this result is unusual. More often a chronic carrier state follows infection. At times it is symptomatic with cardiac and visceral involvement; more often, no significant symptoms are noted, but patients became carriers and are infectious.
Transfusion-transmitted Chagas disease has been reported twice in North America [10, 11] . In each case the suspected carrier had emigrated from South or Central America. Thus, the increasing number of individuals from endemic areas who now live in the U.S. represents a new problem for blood-collecting agencies. There is no good test for donor screening. Current tests have a false-positive rate of 1-3 percent. Adding such a test to the donor-processing routine will be difficult, because so many donors who are not infected will have to be notified about the positive finding and placed on lists of deferred donors. In a like manner, to select Hispanics for testing or to defer them without testing would be socially unacceptable. The Public Health Service is addressing this problem, but no easy solution seems forthcoming. One author has called for an interim policy of not accepting blood from selected donors who have resided in endemic regions [12] . BABESIOSIS Babesiosis has been transmitted by transfusion throughout the world [13, 14] . Splenectomized recipients seem to be at increased risk [15] , and at least one fatal case is reported [16] . There is a reservoir of infected individuals, at first thought to be localized to eastern Long Island and adjacent Connecticut, but now reported in other areas. One study of antibody prevalence in the Cape Cod-Boston, Massachusetts, area found positive results in 3.3-4.9 percent of donors tested [17] . It is not known how many, if any, of these antibody-positive persons are infectious. There is no consensus about what, if anything, should be done to limit the spread of transfusion-transmitted babesiosis. Neither additional questioning about tick bites nor geographic restrictions on summer bloodmobiles seem indicated. Serological testing and/or examination of blood films from all donors is not practical. No reasonable solution to the problem is obvious; the fact that it is, at present, a minor problem, suggests that no action will be forthcoming.
PARVOVIRUS B19 INFECTIONS Parvovirus B19 has been identified as the etiologic agent of erythema infectiosum (fifth disease) in children and as a major cause of the transient aplastic crises seen in patients with hemolytic anemias. It has also been reported to cause severe chronic anemia, particularly in immunodeficient patients.
Parvovirus B 19 seroconversion and infection have been reported after transfusion of factor VII concentrates [18] . So far, the number of reports is small, but the potential for increased interest and awareness is present, especially since a test for antibodies to parvovirus B 19 is becoming more readily available. It may be that in the near future it will be considered appropriate to use parvovirus B 19-negative components for selected patients, in a manner similar to current practice with CMV. LYME DISEASE The association of the spirochete Borrelia burgdorferi with Lyme disease has prompted an interest in whether infected individuals who donate blood could transmit the infection to their recipients [ 19] . There are no reported cases to date, but the setting for such transmission seems so likely that it should be only a matter of time until the first case of transfusion-transmitted Lyme disease is reported. The infection is common, especially during the summer months and especially in the upper northeastern region of the country. There is a period of spirochetemia during which patients may be essentially asymptomatic and therefore eligible to donate blood. The organism survives in blood products under the storage conditions generally used, although these experiments were done using relatively large innocula of Borrelia [20] . It only remains for some astute clinician to suspect Lyme disease and collect the appropriate blood samples before it is added to the ever-growing list of transfusion-transmitted diseases.
The American Association of Blood Banks, in response to the public's interest in this problem, has issued a statement suggesting that: (1) donor testing is not appropriate, even in endemic areas; (2) additional questions at the time of blood donation are not necessary; and (3) neither a tick bite nor a history of Lyme disease with recovery are cause for donor deferral.
While many other diseases have been transmitted by transfusion, in each case the number is small and none are a major problem. Transfusion is safer today than it has ever been. It will be safer tomorrow than it is today, but it will never be absolutely safe. The only transfusion that cannot possibly transmit disease is the one not given.
